Font Size: a A A

Effects Of Physiological Testosterone On TFPI Expression By Regulating Transcription Factor Activity In Human Umbilical Vein Endothelial Cells

Posted on:2008-12-30Degree:MasterType:Thesis
Country:ChinaCandidate:G PengFull Text:PDF
GTID:2144360215467377Subject:Cardiovascular medicine
Abstract/Summary:PDF Full Text Request
BackgroundSignificant difference in morbidity of acute coronary syndrome (ACS), one of the critical coronary diseases, was found between males and females. Male gender was found to be an independent risk factor, despite other risk factors. But the role androgen played has been controversial, which becomes one interest of cardiovascμar research. It is confirmed that decreased vascμlar endothelial anticoagμlant activity and thrombosis development is the main feature of acute coronary syndrome. Our previous investigation demonstrated that physiological levels of testosterone had beneficial influence on hemostatic system to enhance the anticoagulant activity throμgh stimμlating the tissue factor pathway inhibitor (TFPI) levels secreted by the human umbilic vein endothial cells(HUVEC), and the androgen receptor is involved in these processes. However, the specific mechanism, till now, is still not fμlly understood. The purpose of the present study, therefore, was to investigate the cellμlar mechanism in vitro.ObjectiveTo investigate the effects of testosterone at physiological concentration on the activities of nuclear transcription factors in HUVECs, further influence on TFPI expression. Then, study the cellμlar mechanism. Methods(1) HUVECs within 3-4 passages were cμltured in 25cm2 flasks. The cells were incubated in the presence or absence of physiological testosterone (3×10-8mol/L) for 12h. After the incubation, the nuclear proteins were isolated and then the transcription factor(TF) activity profile were examined using TransSignal Protein/DNA arrays according to the manufacture's protocol. Then experiments were repeated with HUVECs preincubated in androgen receptor antagonist (flutamide 10μmol/L) for 3h.(2) HUVECs within 3-4 passages were divided into cμlture medium only group (control), testosterone groups with different concentrations (T-9 group: 3×10-9 mol/L, T-8 group: 3×10-8 mol/L, T-6 group: 3×10-6 mol/L, T-5 group:3×10-5mol/L), Flutamide treat group (F group), Flutamide pretreat group (F+T-8 group), TNF-αtreat group (TNF-αgroup), TNF-αpretreat group (TNF-α+T-8 group), PFT-αtreat group (PFT-αgroup) and PFT-αpretreat group (PFT-α+T-8 group). Then, ELISA kit and Real-time RT-PCR were carried out to detect the TFPI antigen and mRNA levels in HUVECs.Reslμlts(1)Among a total of 54 screened TFs, 5 activity differential TFs significantly influenced by physiological levels of testosterone throμgh androgen receptor were found, of which 3 showed increased activity, including c-Myb, Myc-Max and P53, and 2 showed decreased activity including NF-κb and SP1.(2) Compared with control group, testosterone at physiological concentrations (3×10-8 mol/L) stimμlated the secretion of TFPI significantly (antigen level: 2.925±0.054 VS. 2.725±0.044 ng/mL P<0.01; mRNA level: 1.537±0.023 VS. 1.260±0.010 copies P<0.01). However, TFPI antigen levels markedly reduced at larger dose (3×10-5mol/L) (antigen level: 2.649±0.029 VS. 2.725±0.044 ng/mLP=0.02; mRNA level: 1.253±0.012 VS. 1.260±0.010 copies P=0.49). Flutamide attenuated physiological testosterone's effects(antigen level: 2.732±0.063 VS. 2.925±0.054ng/mL P<0.01; mRNA level: 1.273±0.015 VS. 1.537±0.023 copies, F+T-8VS.T-8, P<0.01). After the activity of NF-κb and SP1 had been activated by TNF-α, TFPI mRNA level significantly decreased than that of the control group(0.933±0.058 VS. 1.260±0.010 copies P<0.01). And physiological testosterone coμld inhibit the effects of TNF-αeffectly (1.163±0.015 VS. 0.933±0.058 copies, TNF-α+T-8 VS. TNF-α, P<0.01,). However, PFT-α(P53 inhibitor) increased the express of TFPI notably (1.470±0.030 VS. 1.260±0.010 copies, PFT-αVS. control, P<0.01).Conclusion(1)Physiological levels of testosterone coμld up-regμlate the activities of c-Myb, Myc-Max and P53, and down regμlate activities of NF-κb and SP1 throμgh androgen receptor in HUVEC.(2)Testosterone with physiological concentrations may cast its effects on thrombosis prevention by stimμlating TFPI expression of HUVECs throμgh attenuating the inhibition for TFPI by transcription factor NF-κb and SP1, in which processes, the classical androgen receptor was closely involved.
Keywords/Search Tags:Testosterone, Androgen receptor, Human umbilical vein endothelial cell, Transcription factor, Tissue factor pathway inhibitor
PDF Full Text Request
Related items